Piperno-Neumann S, Carlino MS, Boni V, et al. A phase I trial of LXS196, a PKC inhibitor for uveal melanoma. SMR 2017, abstract SMR09-1.
Behandeling stadium II-III niet-kleincellig longcarcinoom gaat flink op de schop
apr 2024 | Immuuntherapie, Longoncologie